Bank of America Global Healthcare Conference 2025 September 23, 2025 8:20 AM EDTCompany ParticipantsMichael Farrell - CEO ...
If Mick Farrell is worried about the perceived existential crisis that drugs such as Mounjaro and Ozempic might have on ...
The S9 Elite™ is a whisper quiet, elegant and comfortable therapy system for the treatment of Obstructive Sleep Apnoea (OSA). The S9 Elite provides Continuous Positive Airway Pressure (CPAP) with Easy ...
You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst ...
AUSTIN, Texas and TOKYO, Sept. 19, 2025 /PRNewswire/ — According to DataM Intelligence, the global sleep aids market reached ...
According to DataM Intelligence, the global sleep aids market reached US$ 60.96 billion in 2023, with a rise to US$65.20 billion in 2024 ...
Livewire Markets on MSN
Auscap’s case for active investing and where they’re finding value
There are times where passive investing works but, according to Auscap, the current breakdown of the Australian market isn’t ...
Objectives Up to 77% of patients with obstructive sleep apnoea (OSA) have positional OSA (POSA) but traditional positional therapy (PT) methods have failed as they were poorly tolerated. New ...
Background Continuous positive airway pressure (CPAP) for symptomatic obstructive sleep apnoea (OSA) improves sleepiness and reduces vascular risk, but such treatment for the more prevalent, minimally ...
Objective Obstructive sleep apnoea (OSA), atrial fibrillation (AF) and sudden cardiac death (SCD) may occur concomitantly, and are of considerable epidemiological interest, potentially leading to ...
In the assessment of 12-month price targets, analysts unveil insights for ResMed, presenting an average target of $294.11, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback